Anzeige
Meldung des Tages: Der Vorteil des Meeresbodens: Wie Tiefsee-Knollen den landbasierten Bergbau übertreffen könnten

Sophia Genetics News

Aktie
WKN:  A3CVT8 ISIN:  CH1125843347 US-Symbol:  SOPH Branche:  Gesundheitswesen: Anbieter u. Dienstleister Land:  Schweiz
5,29 $
+0,17 $
+3,32%
4,4968 € 17.04.26
Depot/Watchlist
Marktkapitalisierung *
271,54 Mio. €
Streubesitz
43,93%
KGV
-3,28
Index-Zuordnung
-

Sophia Genetics News

23.09.25 - PR Newswire
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy PR Newswire
22.09.25 - PR Newswire
SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer PR Newswire
22.09.25 - PR Newswire
SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer PR Newswire
08.09.25 - PR Newswire
SOPHiA GENETICS und Jessa Ziekenhuis verkünden Partnerschaft im Bereich der Präzisionsonkologie auf dem Europäischen Kongress für Pathologie
SOPHiA GENETICS und Jessa Ziekenhuis verkünden Partnerschaft im Bereich der Präzisionsonkologie auf dem Europäischen Kongress für Pathologie PR Newswire
05.09.25 - PR Newswire
SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology
SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology PR Newswire
05.09.25 - PR Newswire
SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology
SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology PR Newswire
05.08.25 - PR Newswire
SOPHiA GENETICS Reports Second Quarter 2025 Results
SOPHiA GENETICS Reports Second Quarter 2025 Results PR Newswire
05.08.25 - PR Newswire
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes PR Newswire
05.08.25 - PR Newswire
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes PR Newswire
22.07.25 - PR Newswire
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025
SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025 PR Newswire
06.05.25 - PR Newswire
SOPHiA GENETICS Reports First Quarter 2025 Results
SOPHiA GENETICS Reports First Quarter 2025 Results PR Newswire
28.04.25 - PR Newswire
SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR PR Newswire
28.04.25 - PR Newswire
SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR PR Newswire
22.04.25 - PR Newswire
SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025
SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025 PR Newswire

Newssuche

Videos

newspaper
16.04.26 +2,80%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »